CurrentConnectiCarePolicy MG.MM.ME.59

Biomagnetic Therapy

Customize your policy alerts

Sign up for ConnectiCare Policy MG.MM.ME.59 alerts

Get alerted when Policy MG.MM.ME.59 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

This policy governs ConnectiCare coverage and medical-necessity determinations for biomagnetic therapy, including static magnetic field therapy delivered through devices placed on or near the skin. It applies to providers submitting requests for this treatment and requires clinical evidence for prior-authorization review.

Policy Summary

PayerConnectiCare

PolicyBiomagnetic Therapy

Policy CodePolicy MG.MM.ME.59

Change TypeAdministrative template revision

Effective DateSep 11, 2026

Next Review DateN/A

Key ActionSubmit clinical evidence showing that the patient meets the applicable treatment criteria with every prior-authorization request.

SourceLink

POLICY UPDATE CHANGES

The policy content was transferred to an individual ConnectiCare-branded template.

ConnectiCare adopted the clinical criteria of its parent corporation EmblemHealth.

InvestigationalCoverage classification

Not medically necessaryMedical-necessity determination

97799Procedure code identified

Biomagnetic Therapy Coverage Determination

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentConnectiCarePolicy MG.MM.ME.59

Biomagnetic Therapy

Customize your policy alerts

Sign up for ConnectiCare Policy MG.MM.ME.59 alerts

Get alerted when Policy MG.MM.ME.59 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerConnectiCare

PolicyBiomagnetic Therapy

Policy CodePolicy MG.MM.ME.59

Change TypeAdministrative template revision

Effective DateSep 11, 2026

Next Review DateN/A

Key ActionSubmit clinical evidence showing that the patient meets the applicable treatment criteria with every prior-authorization request.

SourceLink

POLICY UPDATE CHANGES

The policy content was transferred to an individual ConnectiCare-branded template.

ConnectiCare adopted the clinical criteria of its parent corporation EmblemHealth.

InvestigationalCoverage classification

Not medically necessaryMedical-necessity determination

97799Procedure code identified

Biomagnetic Therapy Coverage Determination

Investigational and not medically necessary

Biomagnetic therapy is considered investigational and not medically necessary.

Coverage determination: Biomagnetic therapy is investigational and not medically necessary.

The policy provides no positive medical-necessity criteria or covered-use exception.

Biomagnetic therapy is excluded from medically necessary coverage because it is classified as investigational and not medically necessary.

Biomagnetic therapy is determined to be not medically necessary. The policy provides no positive medical-necessity criteria or covered-use exception for this therapy.

Prior Authorization and Documentation

Prior Authorization

Submit clinical evidence for prior authorization

The treating physician or primary care provider must submit the clinical evidence supporting the request for prior authorization, including evidence that the patient meets the applicable treatment criteria.

Documentation Required

Document that criteria are met

The treating physician or primary care provider must submit clinical evidence demonstrating that the patient meets the criteria for the requested treatment or procedure. Without this documentation and information, ConnectiCare cannot properly review the prior-authorization request.

Denial Risk

Biomagnetic therapy may be denied

Requests for biomagnetic therapy are subject to denial because the therapy is considered investigational and not medically necessary.

Biomagnetic Therapy Overview

Biomagnetic therapy involves placing a magnet on or near the skin to create an electromagnetic field over areas of musculoskeletal damage or perceived discomfort. Devices may include bracelets, necklaces, insoles, sleeves, headbands, and mattress pads. The therapy is also called magnetic therapy, magnetherapy, magnotherapy, static magnetic field therapy, or therapeutic magnets. Proposed uses include degenerative joint conditions such as osteoarthritis and joint or tendon injuries.

Terminology

Biomagnetic therapy

PlacementA magnet is placed on or near the skin.

DevicesDevices may include bracelets, necklaces, insoles, sleeves, head bands, and mattress pads.

Intended effectThe devices create an electromagnetic field over areas of musculoskeletal damage or perceived discomfort.

Alternative names

Magnetic therapyAlternative name for biomagnetic therapy.

MagnetherapyAlternative name for biomagnetic therapy.

MagnotherapyAlternative name for biomagnetic therapy.

Static magnetic field therapyAlternative name for biomagnetic therapy.

Therapeutic magnetsAlternative name for biomagnetic therapy.

Policy Summary

PayerConnectiCare

PolicyBiomagnetic Therapy

Policy CodePolicy MG.MM.ME.59

Change TypeAdministrative template revision

Effective DateSep 11, 2026

Next Review DateN/A

Key ActionSubmit clinical evidence showing that the patient meets the applicable treatment criteria with every prior-authorization request.

SourceLink

On This Page

Biomagnetic Therapy

Sign up for ConnectiCare Policy MG.MM.ME.59 alerts

Biomagnetic Therapy Coverage Determination

Biomagnetic Therapy

Sign up for ConnectiCare Policy MG.MM.ME.59 alerts

Biomagnetic Therapy Coverage Determination

Procedure Codes

Prior Authorization and Documentation

Biomagnetic Therapy Overview

Terminology